163 related articles for article (PubMed ID: 38196829)
21. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
[TBL] [Abstract][Full Text] [Related]
22. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.
Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y
Front Immunol; 2023; 14():1117658. PubMed ID: 36817484
[TBL] [Abstract][Full Text] [Related]
23. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.
Wang J; Ren H; Xu C; Yu B; Cai Y; Wang J; Ni X
Sci Rep; 2024 Apr; 14(1):8238. PubMed ID: 38589454
[TBL] [Abstract][Full Text] [Related]
24. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
25. An Oxidative Stress-Related Genes Signature for Predicting Survival in Bladder Cancer: Based on TCGA Database and Bioinformatics.
Zhang M; Du G; Li Z; Li D; Li W; Li H; Gao X; Tang Z
Int J Gen Med; 2022; 15():2645-2667. PubMed ID: 35300137
[TBL] [Abstract][Full Text] [Related]
26. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of Co-Expressed Immune-Related Gene Signature Affecting the Pattern of Immune Infiltrating in Esophageal Cancer.
Cheng R; Zeng H; Chen L; Zhou L; Dong B
Comb Chem High Throughput Screen; 2023; 26(4):756-768. PubMed ID: 35959623
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.
Zhang Y; Chen K; Wang L; Chen J; Lin Z; Chen Y; Chen J; Lin Y; Xu Y; Peng H
Aging (Albany NY); 2023 Sep; 15(17):8993-9021. PubMed ID: 37665670
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
[TBL] [Abstract][Full Text] [Related]
31. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
32. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
33. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma.
Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW
Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770
[TBL] [Abstract][Full Text] [Related]
34. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558
[No Abstract] [Full Text] [Related]
35. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
36. Increased prognostic value of clinical-reproductive model in Chinese female patients with esophageal squamous cell carcinoma.
Zhang DY; Ku JW; Zhao XK; Zhang HY; Song X; Wu HF; Fan ZM; Xu RH; You D; Wang R; Zhou RX; Wang LD
World J Gastroenterol; 2022 Apr; 28(13):1347-1361. PubMed ID: 35645543
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Ling X; Fang C; Ma J
Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma.
Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K
Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract][Full Text] [Related]
40. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
